CO
Cession Oncology
Cession Oncology focuses on developing novel therapeutic approaches to combat aggressive and difficult-to-treat cancers. The company is advancing targeted treatments designed to overcome resistance mechanisms common in advanced malignancies. Their work aims to improve patient outcomes by addressing unmet needs in oncology care.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Cession Oncology focuses on developing novel therapeutic approaches to address the most aggressive forms of cancer. The company is dedicated to advancing treatments that target hard-to-treat malignancies. Their work centers on creating new options for patients facing deadly cancer diagnoses.